InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: Lykiri post# 222253

Thursday, 04/11/2019 3:16:18 PM

Thursday, April 11, 2019 3:16:18 PM

Post# of 704533
I wonder if Dr. Steven Brem of te interview is the same Steven S. Brem M.D of te Clinical Advisory Board?

Northwest Biotherapeutics

Thema: Presse: Experts guide brain cancer vaccine development


Sep 2005

"We are proud to have such a distinguished Clinical Advisory Board with
some of the world's most respected and experienced experts in the fields of brain cancer, neurology, and clinical design, who will work together to advance our personalized vaccines for the benefit of patients with
Glioblastoma multiforme," said Alton Boynton, Ph.D., President and Chief
Operating Officer of Northwest Biotherapeutics.


The Northwest Biotherapeutics Clinical Advisory Board for DCVax(R)-Brain
is comprised of:
........

Steven S. Brem, M.D.

Dr. Brem is Chief of the Neurosurgery Service, Director, Neuro-Oncology
research laboratory, and Division Chief, Neuro-Oncology, for the H. Lee
Moffitt Cancer Center & Research Institute of the University of South Florida.
Dr. Brem also serves as a New Approaches to Brain Tumor Therapy (NABTT)
Investigator. His research interests include frameless image-guided surgery,
surgery of brain metastasis and malignant tumors, experimental therapeutics,
anti-angiogenesis therapies, pituitary surgery and skull base surgery. Dr.
Brem received a B.A. from Rutgers University and an M.D. from Harvard Medical
School.
https://forum.hirntumorhilfe.de/neuroonkologie/presse-experts-guide-brain-cancer-vaccine-development-568.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News